Skip to content

2006 Press Releases

Dec 21, 2006

Allergan Announces FDA Issues Approvable Letter for COMBIGAN(TM) (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%  

Dec 4, 2006

Allergan Announces New Board Member; Dr. Deborah Dunsire Appointed  

Nov 17, 2006

Allergan Announces FDA Approval of INAMED(R) Silicone-Filled Breast Implants for Breast Augmentation, Reconstruction and Revision Surgery  

Nov 1, 2006

Allergan Reports Third Quarter Operating Results  

Oct 20, 2006

Allergan announces Health Canada grants medical device license to its two silicone-filled breast implant product lines  

Oct 11, 2006

Allergan Announces Quarterly Conference Call  

Oct 5, 2006

Allergan Integrates Inamed's Commercial and Research and Development Operations within New Corporate Division, Allergan Medical  

Sep 26, 2006

Allergan, Inc. Announces Launch of JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS  

Aug 3, 2006

Allergan Proposes Increase in Authorized Shares  

Aug 2, 2006

Allergan Reports Second Quarter Operating Results; Total Product Net Sales Increased 33 Percent for the Second Quarter; Board of Directors Declares Second Quarter Dividend  

Jul 11, 2006

Allergan Announces Quarterly Conference Call  

Jun 23, 2006

Allergan Announces FDA Approval of LUMIGAN(R) as First-Line Treatment for Elevated Eye Pressure in Open-Angle Glaucoma; Indication Expands Approved Uses of LUMIGAN(R) in the Management of Glaucoma  

Jun 5, 2006

Allergan Wins ACULAR(R) Patent Infringement Lawsuit Against Apotex, Inc., Apotex Corp., and Novex Pharma  

Jun 5, 2006

Allergan Announces FDA Approval Of JUVÉDERM™ Gel Family Of Products For The Treatment Of Facial Wrinkles And Folds  

May 25, 2006

Allergan Receives Pan European License for GANFORT(R) (LUMIGAN(R)/Timolol Combination) from European Commission  

May 8, 2006

The Allergan Foundation Donates $2 Million To Advance Eye Research And Treatment  

May 3, 2006

Allergan Reports First Quarter Operating Results; Pharmaceutical Sales Increased 22 Percent for the First Quarter; Board of Directors Declares First Quarter Dividend  

Apr 19, 2006

Allergan Announces Quarterly Conference Call  

Apr 13, 2006

Allergan's Chairman and Chief Executive Officer Adopts Rule 10b5-1 Stock Trading Plan  

Apr 12, 2006

Allergan Completes Note Offerings and Announces Redemption of Zero Coupon Senior Convertible Notes Due 2022  

Showing 1-20 of 43
Page: 1 2 3
 Next 20